CAR-T Cell Therapy for Breast Cancer: From Basic Research to Clinical Application

Breast cancer rises as the most commonly diagnosed cancer in 2020. Among women, breast cancer ranks first in both cancer incidence rate and mortality. Treatment resistance developed from the current clinical therapies limits the efficacy of therapeutic outcomes, thus new treatment approaches are urg...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Yu-Huan, Liu, Jia-Wei, Lu, Chen, Wei, Ji-Fu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8990477/
https://www.ncbi.nlm.nih.gov/pubmed/35414783
http://dx.doi.org/10.7150/ijbs.70120

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8990477/
https://www.ncbi.nlm.nih.gov/pubmed/35414783
http://dx.doi.org/10.7150/ijbs.70120

Ejemplares similares